Position in LIVN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,633,588
+$4,149,887 QoQ
Shares Held
167,300
+35.2% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LIVN Over Time
Shares Held
Position Value (USD)
Derivatives in LIVN
reported options exposure · as of Dec 31, 2022CallValue
$6,664,800
CallShares
120,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,163 | $344,218,967 | |
| 2 | MDT |
Medtronic plc
|
986,367 | $77,163,489 | |
| 3 | GKOS |
GLAUKOS Corp
|
491,636 | $68,711,047 | |
| 4 | ABT |
Abbott Laboratories
|
740,808 | $67,220,917 | |
| 5 | EW |
Edwards Lifesciences Corp
|
456,202 | $41,268,032 | |
| 6 | 739,829 | $18,406,945 | |||
| 7 | BBNX |
Beta Bionics, Inc.
|
855,682 | $13,408,536 | |
| 8 | AXGN |
Axogen, Inc.
|
253,498 | $11,709,072 |
All Filings in LIVN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,633,588 | 167,300 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $6,483,701 | 123,782 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,296,290 | 51,006 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,725,100 | 451,250 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,278,130 | 437,878 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,409,737 | 236,196 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,137,815 | 38,997 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,474,663 | 115,743 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $856,245 | 16,549 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,002,473 | 56,779 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,349,687 | 65,131 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,040,083 | 92,705 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $6,664,800 | 120,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $17,384,408 | 313,007 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,393,449 | 106,233 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $30,504,913 | 488,313 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,019,480 | 159,104 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,955,363 | 388,372 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $51,861,055 | 654,894 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $40,916,739 | 486,467 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,813,241 | 295,853 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,939,108 | 119,908 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $4,213,637 | 87,547 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||